BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 29693337)

  • 1. Impact of Mesenchymal Stem Cells and Vitamin D on Transforming Growth Factor Beta Signaling Pathway in Hepatocellular Carcinoma in Rats.
    Saad El-Din S; Fouad H; Rashed LA; Mahfouz S; Hussein RE
    Asian Pac J Cancer Prev; 2018 Apr; 19(4):905-912. PubMed ID: 29693337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered Cell to Cell Communication, Autophagy and Mitochondrial Dysfunction in a Model of Hepatocellular Carcinoma: Potential Protective Effects of Curcumin and Stem Cell Therapy.
    Tork OM; Khaleel EF; Abdelmaqsoud OM
    Asian Pac J Cancer Prev; 2015; 16(18):8271-9. PubMed ID: 26745072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of mesenchymal stem cells in suppression of hepatocarcinorigenesis in rats: possible role of Wnt signaling.
    Abdel aziz MT; El Asmar MF; Atta HM; Mahfouz S; Fouad HH; Roshdy NK; Rashed LA; Sabry D; Hassouna AA; Taha FM
    J Exp Clin Cancer Res; 2011 May; 30(1):49. PubMed ID: 21545718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
    Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
    Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel chemoprotective effect of tiopronin against diethylnitrosamine-induced hepatocellular carcinoma in rats: Role of ASK1/P38 MAPK-P53 signalling cascade.
    Mo'men YS; Hussein RM; Kandeil MA
    Clin Exp Pharmacol Physiol; 2020 Feb; 47(2):322-332. PubMed ID: 31663622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymoquinone upregulates TRAIL/TRAILR2 expression and attenuates hepatocellular carcinoma in vivo model.
    Helmy SA; El-Mesery M; El-Karef A; Eissa LA; El Gayar AM
    Life Sci; 2019 Sep; 233():116673. PubMed ID: 31336121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory role of Smad7 in hepatocarcinogenesis in mice and in vitro.
    Wang J; Zhao J; Chu ES; Mok MT; Go MY; Man K; Heuchel R; Lan HY; Chang Z; Sung JJ; Yu J
    J Pathol; 2013 Aug; 230(4):441-52. PubMed ID: 23625826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced expression of transcriptional intermediary factor 1 gamma promotes metastasis and indicates poor prognosis of hepatocellular carcinoma.
    Ding ZY; Jin GN; Wang W; Chen WX; Wu YH; Ai X; Chen L; Zhang WG; Liang HF; Laurence A; Zhang MZ; Datta PK; Zhang B; Chen XP
    Hepatology; 2014 Nov; 60(5):1620-36. PubMed ID: 24954480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of KLF4 and consequential downregulation of Smad7 exacerbate oncogenic TGF-β signaling in and promote progression of hepatocellular carcinoma.
    Sun H; Peng Z; Tang H; Xie D; Jia Z; Zhong L; Zhao S; Ma Z; Gao Y; Zeng L; Luo R; Xie K
    Oncogene; 2017 May; 36(21):2957-2968. PubMed ID: 28192402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of TGF-β/Smad signaling by BAMBI blocks differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and abolishes their protumor effects.
    Shangguan L; Ti X; Krause U; Hai B; Zhao Y; Yang Z; Liu F
    Stem Cells; 2012 Dec; 30(12):2810-9. PubMed ID: 23034983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Function-Enhanced Mesenchymal Stem Cells Infected With Decorin-Expressing Adenovirus on Hepatic Fibrosis.
    Jang YO; Cho MY; Yun CO; Baik SK; Park KS; Cha SK; Chang SJ; Kim MY; Lim YL; Kwon SO
    Stem Cells Transl Med; 2016 Sep; 5(9):1247-56. PubMed ID: 27365486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiamin Regresses the Anticancer Efficacy of Methotrexate in the Amelioration of Diethyl Nitrosamine-Induced Hepatocellular Carcinoma in Wistar Strain Rats.
    Saleem S; Kazmi I; Ahmad A; Abuzinadah MF; Samkari A; Alkrathy HM; Khan R
    Nutr Cancer; 2020; 72(1):170-181. PubMed ID: 31088230
    [No Abstract]   [Full Text] [Related]  

  • 13. [Study of mesenchymal stem cells transfected with oncogenes differentiate into hepatocellular carcinoma of rats].
    Zhang GQ; Fang CH; Gao P; Yan Z; Zheng Q; Chen GH
    Zhonghua Wai Ke Za Zhi; 2007 May; 45(9):605-8. PubMed ID: 17688794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The therapeutic effects of bone marrow-derived mesenchymal stem cells and simvastatin in a rat model of liver fibrosis.
    Motawi TM; Atta HM; Sadik NA; Azzam M
    Cell Biochem Biophys; 2014 Jan; 68(1):111-25. PubMed ID: 23807535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential Molecular Targets of Statins in the Prevention of Hepatocarcinogenesis.
    Ridruejo E; Romero-Caími G; Obregón MJ; Kleiman de Pisarev D; Alvarez L
    Ann Hepatol; 2018; 17(3):490-500. PubMed ID: 29735800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin ameliorate DENA-induced HCC via modulating TGF-β, AKT, and caspase-3 expression in experimental rat model.
    Abouzied MM; Eltahir HM; Abdel Aziz MA; Ahmed NS; Abd El-Ghany AA; Abd El-Aziz EA; Abd El-Aziz HO
    Tumour Biol; 2015 Mar; 36(3):1763-71. PubMed ID: 25519685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver specific overexpression of platelet-derived growth factor-B accelerates liver cancer development in chemically induced liver carcinogenesis.
    Maass T; Thieringer FR; Mann A; Longerich T; Schirmacher P; Strand D; Hansen T; Galle PR; Teufel A; Kanzler S
    Int J Cancer; 2011 Mar; 128(6):1259-68. PubMed ID: 20506153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual regulating of mitochondrial fusion and Timp-3 by leflunomide and diallyl disulfide combination suppresses diethylnitrosamine-induced hepatocellular tumorigenesis in rats.
    Abdel-Hamid NM; Abass SA; Eldomany RA; Abdel-Kareem MA; Zakaria S
    Life Sci; 2022 Apr; 294():120369. PubMed ID: 35120919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-β signaling in hepatocytes promotes hepatic fibrosis and carcinogenesis in mice with hepatocyte-specific deletion of TAK1.
    Yang L; Inokuchi S; Roh YS; Song J; Loomba R; Park EJ; Seki E
    Gastroenterology; 2013 May; 144(5):1042-1054.e4. PubMed ID: 23391818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compound Astragalus and Salvia miltiorrhiza extracts modulate MAPK-regulated TGF-β/Smad signaling in hepatocellular carcinoma by multi-target mechanism.
    Boye A; Wu C; Jiang Y; Wang J; Wu J; Yang X; Yang Y
    J Ethnopharmacol; 2015 Jul; 169():219-28. PubMed ID: 25934513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.